BABYO2- silver, zinc liquid

BabyO2 by

Drug Labeling and Warnings

BabyO2 by is a Otc medication manufactured, distributed, or labeled by Oxigenesis, Inc.. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

Active Ingredient                                                           Purpose

Colloidal Silver 48 mg ................................................   Skin Protectant
Colloidal Zinc   6 mg .................................................... Skin Protectant
HOCl 66 mg ...............................................................  Antimicrobial   

PURPOSE

Uses

Relieves and prevents the discomfort and symptoms from: diaper rash, chaffed skin, minor burns and abrasions.

Warnings

• For external use only.
• Do not use over puncture wounds, infections or lacerations. Avoid contact with the eyes. Stop use and ask a doctor if condition worsens or does not improve in 7 days.

KEEP OUT OF REACH OF CHILDREN

Keep out of reach of children.

Directions

Change wet and solid diapers promptly. Cleanse diaper area and dry. Apply serum liberally as often necessary with every diaper change, especially at bedtime.

Other information
Store at 20°-25°C (68° -70° F)

Inactive ingredients

Distilled water, Smectic Clay, Silicon Dioxide, HCl (buffering)

Package Label - Principal Display Panel

INGREDIENTS AND APPEARANCE

BABYO2 
silver, zinc liquid

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 72136-007
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
SILVER (UNII: 3M4G523W1G) (SILVER - UNII:3M4G523W1G)	SILVER	48 mg  in 240 mL
ZINC (UNII: J41CSQ7QDS) (ZINC - UNII:J41CSQ7QDS)	ZINC	6 mg  in 240 mL
HYPOCHLOROUS ACID (UNII: 712K4CDC10) (ZINC - UNII:J41CSQ7QDS)	HYPOCHLOROUS ACID	65.8 mg  in 240 mL

Inactive Ingredients
Ingredient Name	Strength
WATER (UNII: 059QF0KO0R)
LAPONITE (UNII: D703131383)
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
HYDROCHLORIC ACID (UNII: QTT17582CB)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 72136-007-01	240 mL in 1 TUBE; Type 0: Not a Combination Product	09/20/2020

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
unapproved drug other		09/20/2020

Labeler - Oxigenesis, Inc. (006774725)

Establishment
Name	Address	ID/FEI	Business Operations
Oxigenesis, Inc.		006774725	manufacture(72136-007)